Rheumatoid Arthritis - All SharePosts Relating To "Actemra"

EXPERT

Mark Borigini, M.D.

(Profile)

Rheumatologist

Our Expert | Health Professional

RSS

posted 03/03/2008, comments (0)

I've Got Rhythm, I've Got Rheumatoid Arthritis

With apologies to George Gershwin, I thought it might be nice to review with you the importance of the circadian rhythm in rheumatoid arthritis. I am often asked by my patients why they have more pain and stiffness in the morning. After all, I never ask about "evening stiffness." It's always morning stiffness on my mind... Read more Chevron

Read all my posts | Subscribe

EXPERT

Christine Miller

(Profile)

In Remission from JRA, Active April 2006 to February 2009

Our Expert | Living With It

RSS

posted 12/05/2007, comments (0)

Positive Research Results for Available RA Drugs

Earlier in November, the American College of Rheumatology held its 71st annual scientific meeting. Among the many research studies discussed and presented at the meeting, several made the news recently which may offer some hope or comfort to RA sufferers, especially those in the early stages of the disease or who have seropositive RA. First,... Read more Chevron

Read all my posts | Subscribe

EXPERT

Christine Miller

(Profile)

In Remission from JRA, Active April 2006 to February 2009

Our Expert | Living With It

RSS

posted 11/30/2007, comment (1)

Roche files for FDA approval of Actemra

After positive research results were presented at the American College of Rheumatology Annual Scientific Meeting earlier this month, Roche announced this week that it has filed for FDA approval of a biologics license application for its drug tocilizumab (marketed as Actemra) for the treatment of signs and symptoms of RA. As Dr. Borigini explained... Read more Chevron

Read all my posts | Subscribe

EXPERT

Mark Borigini, M.D.

(Profile)

Rheumatologist

Our Expert | Health Professional

RSS

posted 11/28/2007, comment (1)

A New Drug for Rheumatoid Arthritis in 2008?

The American College of Rheumatology Annual Scientific Meeting in Boston last week provided more good data on the new-and investigational--rheumatoid arthritis drug Actemra, an IL-6 inhibitor. Studies of Actemra found that about 60% of the patients taking that drug with a traditional disease modifying drug achieved a 20% reduction in... Read more Chevron

Read all my posts | Subscribe

EXPERT

Christine Miller

(Profile)

In Remission from JRA, Active April 2006 to February 2009

Our Expert | Living With It

RSS

posted 11/19/2007, comments (0)

Study Shows Combination Drug Therapy Reduces Heart Attack Risk in RA Patients

After writing the other week about the depressing research related to mortality rates of RA sufferers and the link to cardiovascular problems, I was pleased to see reports of another study with more positive news for people with RA. Research presented recently at the American College of Rheumatology Annual Scientific Meeting shows that the use of... Read more Chevron

Read all my posts | Subscribe